Results 121 to 130 of about 96,804 (217)

Safety of Baricitinib for the Treatment of Atopic Dermatitis in Adults Over a Median of 1.6 and up to 4.6 Years Treatment: Final Integrated Analysis of Eight Clinical Trials

open access: yesJEADV Clinical Practice, Volume 5, Issue 1, Page 67-74, March 2026.
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo   +11 more
wiley   +1 more source

Peri‐operative rehabilitation in patients undergoing elective cardiac valve surgery: a randomised controlled trial

open access: yesAnaesthesia, Volume 81, Issue 3, Page 362-372, March 2026.
Summary Introduction Patients with valvular heart disease are at high risk of postoperative pulmonary complications, which contribute to morbidity and mortality. However, few studies have focused specifically on peri‐operative rehabilitation in this patient population.
Yuting Liu   +16 more
wiley   +1 more source

Biofilm Associated Persistence and Drug Tolerance in Mycobacteria Within Host Microenvironments

open access: yesAPMIS, Volume 134, Issue 3, March 2026.
ABSTRACT Biofilms formed by mycobacteria, particularly Mycobacterium tuberculosis (Mtb), represent a major challenge in tuberculosis (TB) treatment due to their highly organized structure and their capacity to induce phenotypic drug tolerance. These three‐dimensional bacterial aggregates are embedded in a self‐produced extracellular matrix that ...
Lourdes Serrano Garcia   +3 more
wiley   +1 more source

Impact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study

open access: yesClinical Transplantation, Volume 40, Issue 3, March 2026.
ABSTRACT Objectives Microaxial flow pump devices are utilized as a bridge to heart transplantation for patients in advanced cardiogenic shock. Little is known about the impact of device duration on post‐transplant outcomes. This study aims to compare post‐transplantation outcomes based on duration of support with the Impella 5.5.
David Rekhtman   +12 more
wiley   +1 more source

Infectious seeds of valve calcification: Exploring the bacterial hypothesis in the pathogenesis of calcific aortic valve disease

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 3, March 2026.
Abstract Background Calcific aortic valve disease (CAVD) is a multifactorial condition characterized by progressive leaflet calcification with a potential role for bacterial colonization in its pathogenesis. This study investigates clinical, microbiological and molecular features of calcified versus non‐calcified aortic regurgitation (AR) valves ...
Antonella Forlino   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy